FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “data protection”

Showing 1 - 4 of 4

BUSINESS

Telemedicine: Opportunities and challenges

Business, Peerapan Tungsuwan, Published on 25/09/2017

» In our previous article on Sept 18 we discussed telemedicine, what it means and how it has the potential to help solve many of the challenges confronting healthcare today. In Thailand, telemedicine in public hospitals has the potential to provide improved access to healthcare services for people living in remote areas where there are insufficient doctors and facilities. It also allows the country's private hospitals to remain competitive with international counterparts in medical tourism markets. However, there are unresolved legal and ethical issues concerning telemedicine and in this article we will discuss a few of them.

BUSINESS

Powering the future: The importance and protection of personal health information

Business, Peerapan Tungsuwan, Published on 11/09/2017

» In our previous article, we discussed some of the products that have been innovated, developed, manufactured, assembled and brought to market as a result of new technology, and some of the opportunities and legal implications for their use and regulation.

BUSINESS

Technology in Healthcare: the New Face of Healthcare Delivery

Business, Peerapan Tungsuwan, Published on 26/08/2017

» Technology in healthcare or for the sake of healthcare is not new. It has been around for many years. When we talk about technology in healthcare, it can mean many different things to different people. Terms such as healthtech, meditech and digital health all refer to much the same thing: the partnership between technology and healthcare.

Image-Content

BUSINESS

Price controls of new patented drugs a step in the wrong direction

Business, Peerapan Tungsuwan, Published on 01/06/2015

» In Thailand price controls of drugs have existed for a long time and in many forms. However, for the first time there is a proposal to include direct price control of new patented drugs as part of the approval and registration process.